Embla Medical hf. (CPH:EMBLA)

Denmark flag Denmark · Delayed Price · Currency is DKK
31.80
+0.70 (2.25%)
At close: Oct 1, 2025
2.25%
Market Cap13.53B
Revenue (ttm)5.55B
Net Income (ttm)464.57M
Shares Out425.59M
EPS (ttm)1.09
PE Ratio29.09
Forward PE23.39
Dividendn/a
Ex-Dividend Daten/a
Volume38,510
Average Volume78,634
Open31.10
Previous Close31.10
Day's Range31.10 - 32.10
52-Week Range25.01 - 38.00
Beta0.58
RSI49.77
Earnings DateOct 21, 2025

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and... [Read more]

Sector Healthcare
Founded 1971
Employees 4,061
Stock Exchange Copenhagen Stock Exchange
Ticker Symbol EMBLA
Full Company Profile

Financial Performance

In 2024, Embla Medical's revenue was $854.89 million, an increase of 8.81% compared to the previous year's $785.68 million. Earnings were $68.28 million, an increase of 16.94%.

Financial numbers in USD Financial Statements

News

There is no news available yet.